5 Results for "

ARM domain

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ARM domain" in MCE Product Catalog:

Cat. No.: HY-P991092

Target:  

EGFR CD276/B7-H3

Research Areas:  

Cancer

IBI-334 is a bispecific B7-H3 and EGFR antibody. IBI-334 has an EGFR arm for signal blockage and is coupled with a fine-tuned B7-H3 arm with optimal affinity and binding domain. IBI-334 shows antibody-mediated cell cytotoxicity (ADCC) effects. IBI-334 has a wide range of applications in many EGFR-driven solid tumors .
loading...
    loading...
Cat. No.: HY-182500A
CAS No.: 3020765-70-9
Research Areas:  

Neurological Disease

(S,S)-SARM1-IN-9 (Compound MY-13A) is a stereoselective SARM1 inhibitor with covalent binding properties. (S,S)-SARM1-IN-9 covalently modifies Cys311 in the autoregulatory ARM domain of wild-type SARM1, thereby blocking NADase activity, without inhibiting the SARM1 C311A or SARM1 C311S mutants. (S,S)-SARM1-IN-9 blocks vacor- and vincristine-induced axon degeneration in primary rodent dorsal root ganglion neurons. (S,S)-SARM1-IN-9 can be used for research on axon degeneration-dependent neurological disorders, including chemotherapy-induced peripheral neuropathy .
loading...
    loading...
Cat. No.: HY-P991092A

Target:  

EGFR CD276/B7-H3

Research Areas:  

Cancer

IBI-334 (FUT8-KO) is a bispecific B7-H3 and EGFR antibody that has knocked out the fucosyltransferase 8 gene (FUT8). IBI-334 (FUT8-KO) has an EGFR arm for signal blocking and is coupled with a fine-tuned B7-H3 arm with the best affinity and binding domain. IBI-334 (FUT8-KO), compared to IBI-334 (HY-P991092), has enhanced antibody-mediated cytotoxicity (ADCC) effect. IBI-334 (FUT8-KO) has wide applications in many EGFR-driven solid tumors .
loading...
    loading...
Cat. No.: HY-185782
Research Areas:  

Others

Methyltetrazine-PEG2-tris (PEG3-DBCO) is a methyltetrazine-derived multi-arm PEG crosslinker designed specifically for the inverse electron-demand Diels-Alder (IEDDA) bioorthogonal reaction. Methyltetrazine-PEG2-tris (PEG3-DBCO) contains both methyltetrazine and tris (PEG3-DBCO) domains, and carries DBCO reactive groups. Methyltetrazine-PEG2-tris (PEG3-DBCO) serves as a highly efficient bioorthogonal conjugation reagent .
loading...
    loading...
Cat. No.: HY-182500
CAS No.: 3020765-69-6
Research Areas:  

Neurological Disease

SARM1-IN-9 (Compound MY-13B) is a stereoselective SARM1 inhibitor. SARM1-IN-9 is applicable to research related to axon degeneration-dependent neurological diseases .
loading...
    loading...